title: Modafinil reverses phencyclidine-induced deficits in cognitive flexibility, cerebral metabolism, and functional brain connectivity.
abstract: OBJECTIVE
  In the present study, we employ mathematical modeling (partial least squares regression, PLSR) to elucidate the functional connectivity signatures of discrete brain regions in order to identify the functional networks subserving PCP-induced disruption of distinct cognitive functions and their restoration by the procognitive drug modafinil.
  
  
  METHODS
  We examine the functional connectivity signatures of discrete brain regions that show overt alterations in metabolism, as measured by semiquantitative 2-deoxyglucose autoradiography, in an animal model (subchronic phencyclidine [PCP] treatment), which shows cognitive inflexibility with relevance to the cognitive deficits seen in schizophrenia.
  
  
  RESULTS
  We identify the specific components of functional connectivity that contribute to the rescue of this cognitive inflexibility and to the restoration of overt cerebral metabolism by modafinil. We demonstrate that modafinil reversed both the PCP-induced deficit in the ability to switch attentional set and the PCP-induced hypometabolism in the prefrontal (anterior prelimbic) and retrosplenial cortices. Furthermore, modafinil selectively enhanced metabolism in the medial prelimbic cortex. The functional connectivity signatures of these regions identified a unifying functional subsystem underlying the influence of modafinil on cerebral metabolism and cognitive flexibility that included the nucleus accumbens core and locus coeruleus. In addition, these functional connectivity signatures identified coupling events specific to each brain region, which relate to known anatomical connectivity.
  
  
  CONCLUSIONS
  These data support clinical evidence that modafinil may alleviate cognitive deficits in schizophrenia and also demonstrate the benefit of applying PLSR modeling to characterize functional brain networks in translational models relevant to central nervous system dysfunction.
authors.affiliation: Psychiatric Research Institute of Neuroscience in Glasgow (PsyRING), University of Glasgow, G12 8QQ, UK. Neil.Dawson@strath.ac.uk
authors.forename: Neil
authors.initials: N
authors.lastname: Dawson
authors.forename: Rhiannon J
authors.initials: RJ
authors.lastname: Thompson
authors.forename: Allan
authors.initials: A
authors.lastname: McVie
authors.forename: David M
authors.initials: DM
authors.lastname: Thomson
authors.forename: Brian J
authors.initials: BJ
authors.lastname: Morris
authors.forename: Judith A
authors.initials: JA
authors.lastname: Pratt
mesh_terms: D000818:Animals; D001345:Autoradiography; D001522:Behavior, Animal / Q000187:drug effects*; D001559:Benzhydryl Compounds / Q000627:therapeutic use*; D001921:Brain / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D003071:Cognition / Q000187:drug effects*; D004195:Disease Models, Animal; D006213:Hallucinogens / Q000633:toxicity*; D008297:Male; D000077408:Modafinil; D009434:Neural Pathways / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology*; D010622:Phencyclidine / Q000633:toxicity*; D051381:Rats
chemical_list: D001559:Benzhydryl Compounds; D000697:Central Nervous System Stimulants; D006213:Hallucinogens; D010622:Phencyclidine; D000077408:Modafinil
references.citation: Eur J Neurosci. 2006 Jul;24(2):509-19
references.pmid: 16836637
references.citation: Arch Gen Psychiatry. 1992 Dec;49(12):959-65
references.pmid: 1360200
references.citation: Schizophr Res. 1999 Jun 22;37(3):251-70
references.pmid: 10403197
references.citation: Neuroimage. 2006 Apr 1;30(2):452-61
references.pmid: 16326115
references.citation: Eur J Neurosci. 2000 Apr;12(4):1420-30
references.pmid: 10762370
references.citation: Trends Neurosci. 1991 Jan;14(1):21-7
references.pmid: 1709528
references.citation: J Neurosci. 2007 Oct 24;27(43):11496-500
references.pmid: 17959792
references.citation: Arch Gen Psychiatry. 2007 Jun;64(6):633-47
references.pmid: 17548746
references.citation: Am J Psychiatry. 2006 Dec;163(12):2184-6
references.pmid: 17151173
references.citation: Cereb Cortex. 2007 Jul;17(7):1625-36
references.pmid: 16963518
references.citation: Psychiatry Res. 1997 Oct 31;75(3):145-57
references.pmid: 9437772
references.citation: Brain. 2003 Aug;126(Pt 8):1830-7
references.pmid: 12821528
references.citation: J Pharmacol Exp Ther. 2006 Nov;319(2):561-9
references.pmid: 16885432
references.citation: Neuropharmacology. 2004 Sep;47(4):527-37
references.pmid: 15380371
references.citation: Psychopharmacology (Berl). 2008 Sep;200(1):39-50
references.pmid: 18568443
references.citation: Neuropharmacology. 2000 Aug 23;39(11):1974-83
references.pmid: 10963741
references.citation: J Neurosci. 2005 Jan 12;25(2):532-8
references.pmid: 15647499
references.citation: Neurosci Lett. 2004 Oct 7;369(1):4-8
references.pmid: 15380297
references.citation: Psychopharmacology (Berl). 2005 Apr;179(1):77-84
references.pmid: 15682304
references.citation: Biol Psychiatry. 2004 May 15;55(10):1013-22
references.pmid: 15121486
references.citation: Cereb Cortex. 2007 Sep;17 Suppl 1:i151-60
references.pmid: 17725997
references.citation: Nat Neurosci. 2005 Jun;8(6):805-12
references.pmid: 15908948
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 1992 Apr;345(4):461-5
references.pmid: 1620245
references.citation: Neuropsychologia. 1991;29(10):993-1006
references.pmid: 1762678
references.citation: Acta Psychiatr Scand. 2004 Oct;110(4):243-56
references.pmid: 15352925
references.citation: J Neurosci. 2000 Jun 1;20(11):4320-4
references.pmid: 10818167
references.citation: J Neurosci. 2004 Jun 9;24(23):5331-5
references.pmid: 15190105
references.citation: Ann N Y Acad Sci. 2007 Dec;1121:407-20
references.pmid: 17698991
references.citation: Wien Med Wochenschr. 2006 Apr;156(7-8):179-84
references.pmid: 16823534
references.citation: Br J Psychiatry. 2005 Jul;187:55-61
references.pmid: 15994572
references.citation: Neuron. 2005 Sep 1;47(5):633-6
references.pmid: 16129393
references.citation: Neuroreport. 2002 May 7;13(6):885-90
references.pmid: 11997707
references.citation: J Neurochem. 1977 May;28(5):897-916
references.pmid: 864466
references.citation: J Cereb Blood Flow Metab. 1982 Dec;2(4):487-99
references.pmid: 7142312
references.citation: Am J Psychiatry. 1998 Sep;155(9):1285-7
references.pmid: 9734557
references.citation: Biol Psychiatry. 2009 Sep 15;66(6):586-93
references.pmid: 19576575
references.citation: Am J Psychiatry. 1997 Jun;154(6):805-11
references.pmid: 9167508
references.citation: Psychopharmacology (Berl). 2008 May;198(1):37-49
references.pmid: 18427784
references.citation: Neuroimage. 1996 Jun;3(3 Pt 1):143-57
references.pmid: 9345485
references.citation: J Psychopharmacol. 2007 Mar;21(2):198-205
references.pmid: 17329300
references.citation: Neurobiol Learn Mem. 2008 May;89(4):567-73
references.pmid: 18054257
references.citation: Brain Res. 1995 Jul 31;687(1-2):114-24
references.pmid: 7583295
references.citation: J Clin Psychol. 1991 Jan;47(1):159-69
references.pmid: 2026771
references.citation: Arch Gen Psychiatry. 1992 Jul;49(7):522-30
references.pmid: 1627043
references.citation: Neuroscience. 1992;47(2):251-64
references.pmid: 1641123
references.citation: J Neurosci Res. 2009 Aug 1;87(10):2375-85
references.pmid: 19326435
references.citation: Biol Psychiatry. 2000 Jan 15;47(2):137-43
references.pmid: 10664830
references.citation: Eur J Neurosci. 2002 Mar;15(6):945-52
references.pmid: 11918653
references.citation: Lancet. 1983 Dec 24-31;2(8365-66):1448-52
references.pmid: 6140544
references.citation: Am J Psychiatry. 2002 Feb;159(2):227-37
references.pmid: 11823264
references.citation: Psychopharmacology (Berl). 2009 Oct;206(3):403-14
references.pmid: 19629447
references.citation: Biol Psychiatry. 1990 Feb 15;27(4):377-99
references.pmid: 2106922
references.citation: Brain Res. 2010 Feb 8;1313:143-61
references.pmid: 19961836
references.citation: Science. 2004 May 7;304(5672):878-80
references.pmid: 15131308
references.citation: Am J Psychiatry. 2003 Dec;160(12):2209-15
references.pmid: 14638592
references.citation: Neuropharmacology. 2002 Sep;43(3):394-407
references.pmid: 12243769
references.citation: Neuroimage. 2010 Jan 1;49(1):865-74
references.pmid: 19744566
references.citation: Schizophr Res. 2000 May 25;43(1):33-46
references.pmid: 10828413
references.citation: Neuroreport. 2001 Nov 16;12(16):3573-7
references.pmid: 11733714
references.citation: Neuropsychopharmacology. 2008 Jun;33(7):1477-502
references.pmid: 17712350
references.citation: Cereb Cortex. 2001 Nov;11(11):1015-26
references.pmid: 11590111
references.citation: Biol Psychiatry. 1998 Oct 15;44(8):787-90
references.pmid: 9798085
references.citation: Psychiatry Res. 2003 Feb 15;122(2):69-87
references.pmid: 12714172
references.citation: J Psychopharmacol. 2005 Mar;19(2):149-58
references.pmid: 15728436
references.citation: Neuropsychopharmacology. 2003 Feb;28(2):265-75
references.pmid: 12589379
references.citation: Cereb Cortex. 1998 Jun;8(4):321-45
references.pmid: 9651129
references.citation: Neuroscience. 2008 Apr 22;153(1):63-71
references.pmid: 18355972
references.citation: Science. 1997 Aug 15;277(5328):953-5
references.pmid: 9252326
references.citation: Arch Gen Psychiatry. 1992 Dec;49(12):943-58
references.pmid: 1360199
references.citation: Hum Brain Mapp. 1997;5(4):323-7
references.pmid: 20408236
references.citation: Biol Psychiatry. 2000 Jul 15;48(2):99-109
references.pmid: 10903406
references.citation: Behav Brain Res. 2003 Nov 30;146(1-2):97-103
references.pmid: 14643463
references.citation: Ann Neurol. 1991 Dec;30(6):801-9
references.pmid: 1838680
references.citation: Neuroreport. 2001 Nov 16;12(16):3533-7
references.pmid: 11733706
references.citation: Am J Clin Nutr. 2009 Sep;90(3):875S-880S
references.pmid: 19571222
references.citation: Am J Psychiatry. 1990 Feb;147(2):255-6
references.pmid: 2301671
references.citation: Br J Psychiatry Suppl. 2002 Sep;43:s38-44
references.pmid: 12271799
references.citation: J Neurol Neurosurg Psychiatry. 1995 Apr;58(4):452-6
references.pmid: 7738553
references.citation: Neuropsychopharmacology. 2004 Jul;29(7):1363-73
references.pmid: 15085092
references.citation: Yakubutsu Seishin Kodo. 1991 Feb;11(1):47-8
references.pmid: 1882590
references.citation: Neuroreport. 1997 Sep 8;8(13):2883-7
references.pmid: 9376524
references.citation: J Cereb Blood Flow Metab. 2001 Apr;21(4):404-12
references.pmid: 11323526
references.citation: Schizophr Bull. 2009 Jan;35(1):19-31
references.pmid: 19042912
references.citation: Neurobiol Learn Mem. 2005 Mar;83(2):125-33
references.pmid: 15721796
references.citation: Cereb Cortex. 2009 May;19(5):1042-54
references.pmid: 18787230
references.citation: Brain Res Bull. 2008 Jul 30;76(5):485-92
references.pmid: 18534256
references.citation: Eur J Neurosci. 2007 Jun;25(12):3719-24
references.pmid: 17610591
references.citation: Eur J Pharmacol. 1995 Jan 24;273(1-2):63-71
references.pmid: 7737319
references.citation: J Neurosci. 2006 Mar 1;26(9):2449-57
references.pmid: 16510723
references.citation: Neuropharmacology. 2004 Dec;47(8):1135-45
references.pmid: 15567423
references.citation: Hum Brain Mapp. 2005 May;25(1):60-9
references.pmid: 15846819
references.citation: Eur J Pharmacol. 1996 Jun 13;306(1-3):33-9
references.pmid: 8813612
references.citation: Neuropsychopharmacology. 2005 Jun;30(6):1138-47
references.pmid: 15689962
references.citation: Neuropsychopharmacology. 2001 Jan;24(1):66-74
references.pmid: 11106877
references.citation: Psychopharmacology (Berl). 2009 Jan;202(1-3):287-93
references.pmid: 18392753
references.citation: J Neurosci. 2003 Jan 15;23(2):676-81
references.pmid: 12533627
references.citation: Proc Natl Acad Sci U S A. 2005 Apr 12;102(15):5588-93
references.pmid: 15809416
references.citation: Neuropsychopharmacology. 1997 Aug;17(2):92-9
references.pmid: 9252984
references.citation: Behav Brain Res. 2007 Jun 18;180(2):152-60
references.pmid: 17451820
references.citation: J Clin Psychiatry. 2009 Jan;70(1):104-12
references.pmid: 19026265
references.citation: Am J Psychiatry. 1995 Jun;152(6):876-82
references.pmid: 7755117
references.citation: Eur Neuropsychopharmacol. 1997 Feb;7(1):25-38
references.pmid: 9088882
references.citation: J Neurochem. 2009 Oct;111(2):614-23
references.pmid: 19702657
references.citation: Eur Arch Psychiatry Clin Neurosci. 2001;251(2):66-71
references.pmid: 11407441
references.citation: Schizophr Res. 2007 Jul;93(1-3):296-303
references.pmid: 17482797
references.citation: Schizophr Res. 2003 Jun 1;61(2-3):175-84
references.pmid: 12729869
references.citation: Eur Psychiatry. 1999 Mar;14(1):17-24
references.pmid: 10572321
references.citation: Lancet. 1995 Jun 3;345(8962):1383-4
references.pmid: 7760605